Safeguard Scientifics Inc
NYSE:SFE
Balance Sheet
Balance Sheet Decomposition
Safeguard Scientifics Inc
Current Assets | 16.3m |
Cash & Short-Term Investments | 15.7m |
Other Current Assets | 600k |
Non-Current Assets | 16.1m |
Long-Term Investments | 14.8m |
PP&E | 1.1m |
Other Non-Current Assets | 200k |
Current Liabilities | 1.6m |
Accounts Payable | 100k |
Accrued Liabilities | 1.5m |
Non-Current Liabilities | 900k |
Other Non-Current Liabilities | 900k |
Balance Sheet
Safeguard Scientifics Inc
Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
139
|
112
|
33
|
22
|
21
|
8
|
25
|
16
|
25
|
13
|
|
Cash Equivalents |
139
|
112
|
33
|
22
|
21
|
8
|
25
|
16
|
25
|
13
|
|
Short-Term Investments |
38
|
25
|
31
|
8
|
8
|
38
|
0
|
0
|
5
|
7
|
|
Other Current Assets |
2
|
2
|
6
|
2
|
5
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
179
|
139
|
70
|
33
|
34
|
47
|
26
|
16
|
30
|
21
|
|
PP&E Net |
0
|
0
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
1
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Note Receivable |
8
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
155
|
174
|
181
|
191
|
135
|
96
|
77
|
50
|
22
|
15
|
|
Other Long-Term Assets |
4
|
2
|
2
|
7
|
7
|
3
|
2
|
1
|
0
|
0
|
|
Total Assets |
346
N/A
|
319
-8%
|
258
-19%
|
232
-10%
|
177
-24%
|
146
-17%
|
108
-26%
|
69
-36%
|
54
-22%
|
38
-30%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accrued Liabilities |
5
|
6
|
6
|
6
|
5
|
6
|
2
|
3
|
2
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
41
|
27
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
8
|
7
|
6
|
6
|
46
|
33
|
2
|
4
|
2
|
2
|
|
Long-Term Debt |
50
|
51
|
52
|
53
|
45
|
43
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
1
|
|
Total Liabilities |
61
N/A
|
61
-1%
|
62
+2%
|
62
N/A
|
95
+52%
|
79
-17%
|
6
-93%
|
6
+7%
|
3
-44%
|
3
-10%
|
|
Equity | |||||||||||
Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Retained Earnings |
540
|
545
|
604
|
627
|
716
|
731
|
697
|
737
|
710
|
724
|
|
Additional Paid In Capital |
822
|
820
|
817
|
816
|
813
|
811
|
811
|
808
|
807
|
805
|
|
Treasury Stock |
0
|
19
|
20
|
21
|
17
|
15
|
14
|
10
|
49
|
48
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
285
N/A
|
258
-9%
|
196
-24%
|
170
-13%
|
82
-52%
|
67
-18%
|
102
+52%
|
63
-38%
|
51
-20%
|
35
-32%
|
|
Total Liabilities & Equity |
346
N/A
|
319
-8%
|
258
-19%
|
232
-10%
|
177
-24%
|
146
-17%
|
108
-26%
|
69
-36%
|
54
-22%
|
38
-30%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
22
|
22
|
21
|
20
|
21
|
21
|
21
|
21
|
17
|
16
|